Predictors of Success and Major Complications for Primary Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Infarction An Analysis of the 1990 to 1994 Society for Cardiac Angiography and Interventions Registries by Grassman, Eric D. et al.
Predictors of Success and Major Complications for Primary
Percutaneous Transluminal Coronary Angioplasty in Acute
Myocardial Infarction
An Analysis of the 1990 to 1994 Society for Cardiac Angiography and
Interventions Registries
ERIC D. GRASSMAN, MD, FACC, SARAH A. JOHNSON, MD, FACC,*
RONALD J. KRONE, MD, FACC†
Maywood and Elk Grove, Illinois and Saint Louis, Missouri
Objectives. The purpose of this study was to determine predic-
tors of successful coronary angioplasty for acute myocardial
infarction (MI) and associated predictors of the major complica-
tions of in-hospital mortality and emergency coronary artery
bypass graft surgery.
Background. Primary angioplasty is being increasingly used to
treat acute MI, but factors affecting the success and major
complications have not been well studied. Forty laboratories have
been contributing clinical and procedural data to the Society of
Cardiac Angiography and Interventions (SCA&I) on primary
angioplasty for acute MI.
Methods. Univariable and stepwise multivariable logistic re-
gression analysis of clinical and procedural variables was used to
calculate predictors of success and major complications.
Results. There were 4,366 primary angioplasty procedures
reported from 1990 through 1994, with an overall success rate of
91.5%, an in-hospital mortality rate of 2.5% and a rate of
emergency surgery of 4.3%. Higher laboratory primary angio-
plasty volume and lower age were predictive of success. An
intraaortic balloon pump in place, cardiogenic shock and a
moribund condition had negative predictive effects. Unsuccessful
angioplasty, cardiogenic shock or a moribund state were predic-
tive of in-hospital death. Unsuccessful angioplasty, the absence of
a history of hypertension and the absence of congestive heart
failure were predictive of emergency surgery.
Conclusions. The rates of success and major complications in
the SCA&I Registry are similar to other series. Predictors of
success and major complications can be assessed and may be
useful for risk stratifying candidates for primary angioplasty in
acute MI.
(J Am Coll Cardiol 1997;30:201–8)
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Over the past decade, several large trials of thrombolytic
therapy for acute myocardial infarction (MI) have been com-
pleted (1–7). On the basis of these trials, thrombolytic therapy
has become the standard of care for acute MI. Some of the
disadvantages of this therapy include recurrent ischemia, fail-
ure to achieve arterial patency in ;20% of cases and serious
hemorrhagic complications. Because of these limitations, there
has been increasing interest in the use of primary percutaneous
transluminal coronary angioplasty (PTCA) as an alternative to
thrombolytic therapy. A number of small trials have shown less
recurrent ischemia, early patency rates .90% and low rates of
serious hemorrhage with primary angioplasty (8–10). A recent
larger multicenter study involving 12 institutions, the Primary
Angioplasty in Myocardial Infarction trial (PAMI), showed
that primary angioplasty, compared with tissue-type plasmin-
ogen activator therapy, reduced the combined occurrence of
nonfatal reinfarction or death, was associated with a lower rate
of intracranial hemorrhage and resulted in similar left ventric-
ular systolic function (11).
In the PAMI series, the overall success rate for PTCA
was 97.1%. No patient required emergency coronary artery
bypass graft surgery (CABG) because of the failure of PTCA.
Although the PAMI study indicated a high rate of success,
it did not examine some of the reasons for success or fail-
ure of PTCA. The Society for Cardiac Angiography and
Interventions (SCA&I) maintains an extensive data base of
cardiac catheterization and coronary intervention proce-
dures. One hundred ten cardiac catheterization laboratories
contribute to the Society’s Registry. Of these, 40 have contrib-
uted coronary intervention procedure results to the PTCA
Registry during the period 1990–1994. The purpose of this
study was to calculate predictors of successful PTCA, in-
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hospital mortality and emergency CABG for PTCA performed
as primary therapy for acute MI from the SCA&I 1990 to 1994
Registry data.
Methods
Patient selection. From January 1, 1990 to December 31,
1994, 78,199 coronary intervention procedures were reported
in the SCA&I Registry. Of these, 4,366 were performed within
24 h of the onset of an acute MI without the administration of
thrombolytic therapy, and form the basis for this analysis.
Demographic and clinical variables were used and compared
with the end points of successful PTCA, emergency CABG or
in-hospital mortality. The PTCA Registry has been described
in detail in a previous publication (12). The PTCA Registry
variables include the procedures performed; the occurrence of
previous PTCA, previous CABG and acute and previous MI;
the presence of diabetes, hypertension, impaired renal func-
tion, dialysis, cardiogenic shock, moribund status, unstable
angina, congestive heart failure (CHF) and previous dye
allergy; contrast medium; procedure details; vessel treated;
and indication of success and complications.
Variable definitions. Acute MI is defined as a Q wave or
non–Q wave MI as manifested by electrocardiographic
changes or an increase in cardiac enzymes, or both, within the
past 24 h. Diabetes is defined for patients receiving oral
hypoglycemic agents or insulin. Hypertension is defined as
diastolic pressure $100 mm Hg, or if patients are receiving
antihypertensive medications. Impaired renal function refers
to a creatinine level .2 mg/dl. Unstable angina is defined as
crescendo angina despite good medical therapy with or without
rest ischemic changes. Congestive heart failure includes but is
not limited to pulmonary edema, jugular venous distention
hepatomegaly, gallop rhythm or peripheral edema. Cardio-
genic shock is defined as unsupported systolic pressure
,80 mm Hg with a heart rate .95 beats/min, peripheral signs
of vascular collapse such as cool, moist skin and a rapid thready
pulse, decreased urinary output and rapid, shallow breathing.
Moribund status includes patients entering the laboratory in
cardiogenic shock, on a ventilator or intraaortic balloon pump
(IABP), on high doses of vasopressors or receiving cardiopul-
monary resuscitation. Several variables from the data base
fields were selected for analysis. These were laboratory volume
of PTCA for acute MI, age, gender, intracoronary thrombol-
ysis, use of the IABP, previous MI, previous CABG, diabetes,
hypertension, shock, moribund state, CHF and previous PTCA
at the same site. In addition, the occurrence of emergency
CABG and hospital mortality were examined and compared
with other series.
Statistics. We used univariable analysis, followed by mul-
tivariable logistic regression analysis (13), to identify indepen-
dent predictive variables from the categoric and continuous
variables. Forward and backward stepwise regression was
performed. Odds ratios (ORs) were provided to estimate the
probability of patients with a given variable having an in-
creased likelihood of successful angioplasty outcome, having
in-hospital death or having emergency CABG, as compared
with all other patients without the variable. Stepwise multiva-
riable logistic regression analysis was used to identify predic-
tors of success and the aforementioned complications. The
95% confidence interval (CI) of the OR was computed, and if
the 95% CI did not contain the value 1, the association
between the predictor and successful outcome was statistically
significant at the 0.05 level. All analyses were performed
using standard statistical software (SYSTAT 5.1, LOGIT 2.0,
PRIMER). Categoric data are presented as numbers and
percentages, and continuous variables are presented as mean
value 6 SD.
The effect of operator volume on successful PTCA was
studied by calculating the correlation coefficient between op-
erator volume and the percentage of that operator’s successful
cases in primary PTCA for acute MI.
Results
Patients. The clinical and angiographic characteristics of
the patients are shown in Tables 1 and 2. The average number
of angioplasty procedures for acute MI per laboratory in the
1990–1994 Registries was 23, with a minimum of one proce-
dure and a maximum of 145 procedures (median 16). In
patients with no previous CABG, the coding system did not
identify the infarct-related vessel. The success rate for PTCA
was 91.5%. There were 116 in-hospital deaths, for a mortality
rate of 2.6%. Emergency CABG was performed 150 times, for
a rate of 3.4%.
Successful PTCA. Unvariable analysis of successful PTCA
is shown in Table 3. Successful PTCA occurred more fre-
quently in high volume laboratories, with younger patients,
when no IABP was in place, when the patient was not in
cardiogenic shock or moribund and when the patient had no
previous CABG. The variable that achieved statistical signifi-
cance on multivariable logistic regression analysis as a predic-
tor of success was laboratory primary PTCA volume (OR
1.002, 95% CI 1.000 to 1.005, p 5 0.04, for each additional
primary PTCA). Predictors of an unsuccessful procedure were
age (OR 0.99, 95% CI 0.99 to 0.98, p 5 0.004, for each
additional year of age), an IABP in place (OR 0.48; CI 0.62 to
0.37, p , 0.001), cardiogenic shock (OR 0.64, 95% CI 0.89 to
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CHF 5 congestive heart failure
CI 5 confidence interval
IABP 5 intraaortic balloon pump
MI 5 myocardial infarction
OR 5 odds ratio
PAMI 5 Primary Angioplasty in Myocardial Infarction trial
PTCA 5 percutaneous transluminal coronary angioplasty
SCA&I 5 Society of Cardiac Angiography and Interventions
TIMI 5 Thrombolysis in Myocardial Infarction
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0.45, p 5 0.009) and moribund status (OR 0.48, 95% CI 0.74 to
0.32, p 5 0.001). The ORs are shown graphically in Figure 1.
As one can see, higher laboratory volume was slightly predic-
tive of success, and older age was more likely to predict an
unsuccessful result. An IABP in place, cardiogenic shock and a
moribund status were predictive of an unsuccessful result.
Hospital death. Univariable analysis of hospital death is
shown in Table 4. Hospital survivors were younger and treated
in high volume laboratories. Variables occurring more fre-
quently for hospital deaths were female gender, an IABP in
place, a history of hypertension, cardiogenic shock, moribund
status, and CHF. Interestingly, hospital survivors more fre-
quently had a previous MI. Variables predictive of in-hospital
death (Fig. 2) with multivariable analysis were unsuccessful
PTCA (OR 0.14, 95% CI 0.23 to 0.09, p , 0.0001), cardiogenic
shock (OR 8.52, 95% CI 13.85 to 5.24, p , 0.0001) and
moribund status (OR 2.94, 95% CI 5.35 to 1.61, p , 0.0001).
Emergency CABG. Univariable analysis of the need for
emergency CABG is shown in Table 5. Variables occurring
more frequently for patients needing emergency CABG were
IABP, cardiogenic shock, moribund status and previous suc-
cessful PTCA performed at a different site. Patients not
requiring emergency CABG more frequently had a history of
hypertension or had CHF. Variables predictive of emergency
CABG from multivariable analysis (Fig. 3) were the absence of
hypertension (OR 0.55, 95% CI 0.87 to 0.34, p 5 0.012), the
absence of CHF (OR 0.10, 95% CI 0.75 to 0.01, p 5 0.025) and
unsuccessful PTCA (OR 0.02, 95% CI 0.03 to 0.01, p ,
0.0001).
The correlation between operator volume in performing
primary PTCA and the percentage of successful cases was low
(r 5 0.46).
Discussion
Success. The success rate of angioplasty in MI has been
reported as 85% to 97% (11,14–19). The overall success rate
in the 5 years of the Registry was 91.5%. This is somewhat
less than the success rates in these other series. In the Socie-
ty’s registries, however, the success rates progressively in-
creased over the 5-year period 1990–1994, from 86.7%, 87.4%,
90.6%, 91.3% to 92.4%, respectively. Many of the previously
cited references with higher success rates were reported in
1993 and 1994. It appears then that the success rates are
comparable to those reported in other series. The low corre-
lation between operator PTCA volume and percentage of
successful PTCA reported should be taken with a note of
caution. For example, the overall number of procedures (in-
cluding those for acute MI) done by individual operators in
1990 varied from 1 to 232.
In our series the variables that were predictive of unsuc-
cessful angioplasty were older age, lower laboratory PTCA
volume, the presence of an IABP, moribund status and car-
diogenic shock. An IABP is an obvious predictor because it is
usually associated with sicker patients. Intuitively, one would
expect that higher volume institutions would tend to have more
successful results than those institutions with a lower volume.
In contrast, one can argue that most laboratories should tend
to have similar success rates because of selection bias. High
Table 1. Clinical Characteristics of 4,366 Patients
Age (yr) 61 6 12.0
Gender
Female 29.9%
Male 70.1%
Intracoronary thrombolysis
No 88.3%
Yes 11.7%
IABP
No 87.2%
Yes 12.8%
Prior CABG
No 94.5%
Yes 5.5%
Diabetes
No 87.3%
Yes 12.7%
Hypertension
No 71.2%
Yes 28.8%
Cardiogenic shock
No 92.8%
Yes 7.2%
Moribund
No 96.5%
Yes 3.5%
Unstable angina
No 62.0%
Yes 38.0%
CHF
No 94.8%
Yes 5.2%
Data presented are mean 6 SD or percent of patients. CABG 5 coronary
artery bypass graft surgery; CHF 5 congestive heart failure; IABP 5 intraaortic
balloon pump.
Table 2. Vessel Characteristics
% of
Vessels
Prior successful PTCA (n 5 606)
Same site 75.2
Different site 24.8
Vessel treated
Prior CABG (n 5 305)
Coronary artery 50.8
SVG 49.2
No prior CABG (n 5 5,177)
LAD 41.6
LCx 17.8
RCA 40.6
CABG 5 coronary artery bypass graft surgery; LAD 5 left anterior
descending coronary artery; LCx 5 left circumflex coronary artery; PTCA 5
percutaneous transluminal coronary angioplasty; RCA 5 right coronary artery;
SVG 5 saphenous vein graft.
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volume laboratories may choose more difficult cases and low
volume sites less difficult cases, resulting in similar success
rates. The OR for success as a function of laboratory volume
(Fig. 1) was barely greater than zero, supporting the latter
argument. In PAMI II it was found that successful PTCA was
independent of operator or institutional volume (20). This may
in part reflect the experience gained in the first PAMI trial and
the fact that the participating institutions may have been highly
selected. The presence of an IABP, cardiogenic shock and
moribund status are somewhat similar variables, and it is not
surprising that they were all predictive of an unsuccessful
result. Hibbard et al. (21) reported on 45 patients in cardio-
genic shock with acute MI for which emergency PTCA was
performed. Only 62% of these patients had successful dilation
of the infarct-related artery. The higher success rate for our
Registry patients cannot be explained. The definition of car-
diogenic shock for the Registry is unsupported systolic blood
pressure ,80 mm Hg with a heart rate .95 beats/min,
peripheral signs of vascular collapse, decreased urinary output
and rapid, shallow breathing. This definition is similar to that
of other registries, but an audit of compliance with the
definition was not done. Bedotto et al. (19) reported on 750
patients who had direct angioplasty for acute MI. Patients in
the failure group were more likely to be in cardiogenic shock,
to have had a previous MI and to have three-vessel coronary
Table 3. Patient Variables for Successful Versus Unsuccessful Results
Variable No. of Pts Successful PTCA Unsuccessful PTCA p Value
Lab vol 71.7 6 57.0 64.7 6 51.0 0.012
Age (yr) 60.3 6 12.1 62.4 6 11.4 , 0.0001
Gender 0.085
Female 1,305 88.5% 11.5%
Male 3,061 89.9% 10.1%
Intracoronary thrombolysis 0.394
No 3,853 89.6% 10.4%
Yes 513 88.3% 11.7%
IABP , 0.0001
No 3,806 90.9% 9.1%
Yes 560 79.6% 20.4%
Prior CABG 0.042
No 4,127 89.7% 10.3%
Yes 239 85.4% 14.6%
Diabetes 0.097
No 3,812 89.5% 10.5%
Yes 554 89.5% 10.5%
Hypertension 0.476
No 3,110 89.3% 10.7%
Yes 1,256 90.0% 10.0%
Cardiogenic shock , 0.0001
No 4,053 90.4% 9.6%
Yes 313 77.6% 22.4%
Moribund , 0.0001
No 4,214 90.0% 10.0%
Yes 152 74.3% 25.7%
CHF 0.752
No 4,137 89.5% 10.5%
Yes 229 88.6% 11.4%
Prior successful PTCA 0.397
Same site 449 85.7% 14.3%
Different site 153 88.9% 11.1%
Data presented are mean value 6 SD or number or percent of patients (Pts). Lab vol 5 laboratory volume; other
abbreviations as in Tables 1 and 2.
Figure 1. Predictors of successful PTCA for acute MI. LAB 5
laboratory.
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artery disease. Independent predictors of failed angioplasty
were cardiogenic shock and the presence of multivessel coro-
nary artery disease. In their series (19), age did not seem to
play a role in the accomplishment of successful angioplasty.
The extent of coronary artery disease (one-, two- or three-
vessel disease) in the Society’s PTCA Registry was not avail-
able for comparison with this study.
Emergency CABG. In the 5 years of the Registry, emer-
gency CABG was performed 150 times, for a rate of 3.43%.
Other series have reported emergency CABG rates ranging
from 0% to 7.9% (11,14). In PAMI no patient required
emergency CABG. As noted before, however, many of the
centers participating in that trial had a high volume of proce-
dures and had extensive experience. Predictors of emergency
CABG were unsuccessful PTCA (as one would expect) and the
absence of CHF and hypertension. Congestive heart failure
may not be protective but may reflect a reluctance to perform
Figure 2. Predictors of emergency CABG during PTCA for acute MI.
Table 4. Patient Variables in Hospital Survivors Versus Hospital Deaths
Variable No. of Pts Hospital Survivor Hospital Death p Value
Lab vol 60.19 6 46.1 50.25 6 44.1 0.037
Age (yr) 60.4 6 12.0 64.93 6 11.2 , 0.0001
Gender 0.006
Female 1,305 96.9% 3.1%
Male 3,061 98.2% 1.8%
Intracoronary thrombolysis 0.592
No 3,853 97.8% 2.2%
Yes 513 98.2% 1.8%
IABP , 0.0001
No 3,806 98.5% 1.5%
Yes 560 93.2% 6.8%
Prior MI 0.008
No 3,690 97.6% 2.4%
Yes 676 99.3% 0.7%
Prior CABG 0.891
No 4,127 97.8% 2.2%
Yes 239 97.9% 2.1%
Diabetes 0.084
No 477 84.1% 15.9%
Yes 77 75.3% 24.7%
Hypertension , 0.0001
No 3,805 98.2% 1.8%
Yes 561 95.4% 4.6%
Cardiogenic shock , 0.0001
No 4,053 98.8% 1.2%
Yes 313 85.0% 15.0%
Moribund , 0.0001
No 4,214 98.3% 1.7%
Yes 152 83.6% 16.4%
CHF , 0.0001
No 4,137 98.1% 1.9%
Yes 229 93.4% 6.6%
Prior successful PTCA 0.397
Same site 449 97.8% 2.2%
Different site 153 98.7% 1.3%
Data presented are mean value 6 SD or number or percent of patients. MI 5 myocardial infarction; other
abbreviations as in Tables 1 to 3.
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the operation in that clinical situation. The negative power of
hypertension in predicting CABG is interesting but cannot be
explained with the existing data.
In-hospital mortality. The in-hospital mortality rate in the
5 years of the Society’s Registry was 2.66%. This compares
with mortality rates ranging from 2% to 10%, with the majority
being in the range of 2% to 4% (19,21–25). Thus, the mortality
rate for direct angioplasty in the Society’s series seems to be
comparable to that reported by other institutions. In the
National Registry of Myocardial Infarction Primary PTCA
report of March 28, 1996, the mortality rate was 7.9% for
nontransfer-in patients. In this series the infarct was antero-
septal in 37% of the patients, whereas in the SCA&I Registry
this percentage was 25%. In addition, the average ejection
fraction of our patients was 46%. Thus, our lower mortality
may reflect a lower risk group of patients. The lower mortality
rates may also be due to variations in reporting methods
among hospitals. Some hospitals follow patients throughout
their hospital period, by their catheterization laboratory staff
or their quality assurance departments, or both. The variation
of this follow-up from hospital to hospital is unknown.
It is known that Thrombolysis in Myocardial Infarction
(TIMI) flow rates correlate with success and survival. Unfor-
tunately, rates after angioplasty are not a part of the SCA&I
data base. We were able to assess one specific institution’s
TIMI flow rates for 1993 and 1994. A TIMI flow grade of 3 was
achieved in 84.2% of the cases. Although 11% of our patients
received intracoronary thrombolytic therapy, which is higher
than the 5% in the PAMI series, this higher percentage
probably reflects thrombolysis being more commonly done in
the early 1990s throughout the country. Bailout stents were
very infrequently used because of their unavailability to most
of the participating laboratories.
Miller et al. (14) analyzed 117 patients who had undergone
primary angioplasty for acute MI in a single institution.
Variables that were analyzed were age, gender, previous MI,
the presence of cardiogenic shock, the specific infarct-related
vessel, stenosis severity (subtotal or total) and the occurrence
of successful PTCA. They found that older age, the presence of
cardiogenic shock and unsuccessful angioplasty were more
frequently seen in the patients with in-hospital deaths. Table 4
shows our univariable analysis from the 1990–1994 Registries.
Table 5. Patient Variables: No Emergency Versus Emergency Coronary Artery Bypass Graft Surgery
Variable No. of Pts No CABG CABG p Value
Lab vol 60.1 6 46.0 57.5 6 46.4 0.512
Age (yr) 60.5 6 12.1 60.9 6 10.1 0.7
Gender 0.351
Female 1,305 96.4% 3.6%
Male 3,061 97.0% 3.0%
Intracoronary thrombolysis 0.964
No 3,853 96.8% 3.2%
Yes 513 96.7% 3.3%
IABP , 0.0001
No 3,806 97.2% 2.8%
Yes 560 94.1% 5.9%
Prior MI 0.231
No 3,690 96.7% 3.3%
Yes 676 97.6% 2.4%
Prior CABG 0.239
No 4,127 96.7% 3.3%
Yes 239 98.3% 1.7%
Diabetes 0.58
No 525 76.4% 23.6%
Yes 73 79.5% 20.5%
Hypertension 0.01
No 3,110 96.4% 3.6%
Yes 1,256 97.9% 2.1%
Cardiogenic shock , 0.0001
No 4,122 97.2% 2.8%
Yes 288 92.4% 7.6%
Moribund , 0.0001
No 4,205 97.2% 2.8%
Yes 152 91.4% 8.6%
CHF , 0.025
No 4,137 96.7% 3.3%
Yes 229 99.6% 0.4%
Prior successful PTCA , 0.0001
Same site 449 92.0% 8.0%
Different site 189 80.4% 19.6%
Data presented are mean value 6 SD or percent of patients. Abbreviations as in Tables 1 to 4.
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In our series, younger patients from higher volume laborato-
ries; male patients; those not in cardiogenic shock or requiring
an IABP; those with no previous MI; those without hyperten-
sion, cardiogenic shock, moribund status or CHF; and those
having successful angioplasty more frequently survived during
their hospital stay. Thus, our findings are similar to these
investigators for this univariable analysis. For multivariable
analysis, however (Fig. 2), age and gender were not indepen-
dent predictors of in-hospital death.
O’Keefe et al. (15) analyzed several variables as predictors
of in-hospital mortality during primary angioplasty for acute
MI. These variables included the presence of cardiogenic
shock, age $70 years, the occurrence of failed angioplasty and
previous CABG. O’Keefe et al. found that cardiogenic shock,
age $70 years and failed angioplasty were predictors of
in-hospital death. Kimmel et al. (26) analyzed all of the 1992
PTCA data (not just that of primary PTCA for acute MI) of
the SCA&I for predictors of major complications (emergency
CABG, MI or death). Predictors of major complications were
multivessel disease, unstable angina, recent MI, a type C lesion
or left main coronary angioplasty, shock, age, geographic
region and absence of previous CABG. The fact that we found
only three predictors of death is probably due to our narrower
patient group and narrower end point of only deaths. In
another Registry study, Kimmel et al. (27) analyzed the
relation between coronary angioplasty procedure volume and
major complications. Using multivariable analysis they found a
statistically significant decrease in major complications (death,
MI, emergent CABG) when laboratories performing more
than 400 procedures/year are compared with those performing
fewer than 200/year. The relation did not exist for our analysis
of predictors of death or emergency CABG, but it did appear
for successful PTCA outcome. Again, the reason for the
difference may be in their larger combined end point (death,
MI or emergency CABG).
The value of the data in this study may be in “risk
stratifying” primary PTCA and outcomes and expectations.
Certainly, if there is a “score card,” the expectations of success
should be weighted by the results of studies like these. It is
important that the lower success rate and higher mortality of
these patients (referring to moribund, cardiogenic shock, very
elderly) be considered when evaluating the quality of a labo-
ratory, because if it is not, this may have a very chilling effect
on the willingness of laboratories to accept these high risk
patients.
Some of the limitations of this study include the fact that
the data are from a registry where the data entry is not
monitored or proctored, and there is no core laboratory
evaluating the angiograms. Some in-hospital deaths may go
undetected if there is no follow-up after the patient leaves the
laboratory. In contrast, because all the laboratories use the
data for quality control, there is an effort to code the data
accurately. Another limitation is that there is the potential for
selection bias—that is, perhaps only patients who would ap-
pear to be lower risk, with a higher probability of success, were
treated with primary angioplasty. In a review of diagnostic
catheterizations done at the participating institutions, 7,423
patients labeled as having an acute MI underwent angiography
within 24 h of admission. The 4,366 patients who had primary
PTCA thus represent 58.4% of the group. So it appears that
the majority of the patients thought to be eligible for PTCA
underwent the procedure.
The SCA&I receives coronary angioplasty data from a
variety of different institutions. These probably represent a
fairly general reflection of types of institutions across the
United States, ranging from small community hospitals to large
academic institutions. The rates of emergency CABG and
in-hospital mortality appear to be comparable to those re-
ported by other institutions. Higher volume centers seem to
have higher success rates in direct angioplasty. Older patients
are less likely to have a successful result, but this may be a
reflection of other unknown factors. Cardiogenic shock in
other series and in ours is more likely to predict an unsuccess-
ful result. Variables predictive of in-hospital death were un-
successful PTCA, cardiogenic shock or moribund status. Vari-
ables predictive of emergency CABG were unsuccessful PTCA
and the absence of hypertension and CHF.
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